Legend Biotech
LEGN
LEGN
148 hedge funds and large institutions have $2.87B invested in Legend Biotech in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 50 increasing their positions, 49 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 140 → 148 (+8)
2% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 49
0.39% more ownership
Funds ownership: 16.69% → 17.08% (+0.39%)
Holders
148
Holding in Top 10
7
Calls
$47.7M
Puts
$15.5M
Top Buyers
| 1 | +$233M | |
| 2 | +$41.7M | |
| 3 | +$31.2M | |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
+$27.2M |
| 5 |
SC
Samlyn Capital
New York
|
+$25M |
Top Sellers
| 1 | -$138M | |
| 2 | -$63.4M | |
| 3 | -$33.7M | |
| 4 |
CII
Capital International Inc
Los Angeles,
California
|
-$29M |
| 5 |
FFM
FengHe Fund Management
Singapore
|
-$28.7M |